PL358123A1 - Kompozycja - Google Patents

Kompozycja

Info

Publication number
PL358123A1
PL358123A1 PL01358123A PL35812301A PL358123A1 PL 358123 A1 PL358123 A1 PL 358123A1 PL 01358123 A PL01358123 A PL 01358123A PL 35812301 A PL35812301 A PL 35812301A PL 358123 A1 PL358123 A1 PL 358123A1
Authority
PL
Poland
Prior art keywords
release phase
composition
paracetamol
unique
pharmaceutical composition
Prior art date
Application number
PL01358123A
Other languages
English (en)
Other versions
PL203649B1 (pl
Inventor
Shing Yue Chan
Timothy James Grattan
Bounkhiene Sengmanee
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL358123(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of PL358123A1 publication Critical patent/PL358123A1/pl
Publication of PL203649B1 publication Critical patent/PL203649B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Confectionery (AREA)
PL358123A 2000-04-19 2001-04-12 Kompozycja w postaci tabletki dwuwarstwowej zawieraj acej faz e o natychmiastowym uwalnianiu i faz e o przed luzonym uwalnianiu paracetamolu PL203649B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0009522.4 2000-04-19
GBGB0009522.4A GB0009522D0 (en) 2000-04-19 2000-04-19 Composition
PCT/EP2001/004302 WO2001080834A1 (en) 2000-04-19 2001-04-12 Composition

Publications (2)

Publication Number Publication Date
PL358123A1 true PL358123A1 (pl) 2004-08-09
PL203649B1 PL203649B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
EA200200954A1 (ru) 2003-04-24
CN100335046C (zh) 2007-09-05
HU230033B1 (hu) 2015-05-28
US7943170B2 (en) 2011-05-17
JP2003531165A (ja) 2003-10-21
NZ521799A (en) 2004-12-24
US20110177168A1 (en) 2011-07-21
CO5280073A1 (es) 2003-05-30
US20040202716A1 (en) 2004-10-14
CZ303275B6 (cs) 2012-07-11
CZ20023470A3 (cs) 2003-03-12
TWI282286B (en) 2007-06-11
AU6021201A (en) 2001-11-07
WO2001080834A1 (en) 2001-11-01
KR20030009440A (ko) 2003-01-29
ES2329971T3 (es) 2009-12-03
CA2406373A1 (en) 2001-11-01
AU2001260212C1 (en) 2020-07-16
KR100845660B1 (ko) 2008-07-10
EP1274402B1 (en) 2009-08-05
CA2406373C (en) 2010-06-29
EA006103B1 (ru) 2005-08-25
BR0110129A (pt) 2002-12-31
EP1274402A1 (en) 2003-01-15
CY1109483T1 (el) 2014-08-13
GB0009522D0 (en) 2000-06-07
ATE438388T1 (de) 2009-08-15
ZA200208084B (en) 2003-10-08
HUP0300698A2 (hu) 2003-07-28
DK1274402T3 (da) 2009-11-16
MXPA02010347A (es) 2003-04-25
HK1053601A1 (en) 2003-10-31
UA76417C2 (en) 2006-08-15
DE60139462D1 (de) 2009-09-17
HUP0300698A3 (en) 2004-09-28
AU2001260212B2 (en) 2006-09-21
CN1426298A (zh) 2003-06-25

Similar Documents

Publication Publication Date Title
AU6021201A (en) Composition
CY2021020I1 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
TWI235068B (en) Sustained-release pharmaceutical composition
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
EP1251834A4 (en) REDUCED FORM OF COENZYME Q IN STABLE DOSAGE FORMS WITH HIGH BIOAVAILABILITY AND CORRESPONDING APPLICATIONS
AU2001286940A1 (en) Drug delivering prostheses and methods of use
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
GB0017060D0 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
EP1322158A4 (en) METHODS-CONTAINING PHARMACEUTICAL COMPOSITIONS WITH DELAYED ACTIVE INGREDIENTS AND METHOD FOR THE PRODUCTION THEREOF
AU9473601A (en) Stable solid dosage forms of amino acids and processes for producing same
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
AU2001297611A1 (en) Pharmaceutical uses and synthesis of diketopiperazines
DK1227797T3 (da) Farmaceutiske faststofdispersionsformuleringer
AU2002210894A1 (en) Sustained release delivery system and uses thereof
AU2001291744A1 (en) Arylpiperazine derivatives and their use as psychotropic agents
MY136370A (en) Oxazolidinone tablet formulation
PL350054A1 (en) Sustained release salts of pharmaceutically active peptides and their production
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
AU2002302247A1 (en) Genes and proteins involved in the biosynthesis of enediyne ring structures
GB0027691D0 (en) Location dependent display of material
PL357906A1 (pl) Środki przeciwnadciśnieniowe i ich zastosowanie
AU2002221139A1 (en) Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
NZ521515A (en) Composition comprising paracetamol and niflumic acid
AU2001248750A1 (en) Novel physiologically active peptides and use thereof